Inhibitors of tyk2
US-2024425484-A1 · Dec 26, 2024 · US
Kinase inhibitors and method of treating cancer with same
US8980934B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8980934-B2 |
| Application number | US-201313923982-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 21, 2013 |
| Priority date | Jun 22, 2012 |
| Publication date | Mar 17, 2015 |
| Grant date | Mar 17, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present teachings provide a compound represented by structural formula (I): or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.
First claim
Opening claim text (preview).
What is claimed is: 1. A compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein: each R 1 is independently selected from —H, -halogen, —CN, —NO 2 , OR c , —NR a R b , —S(O) i R c , —NR d S(O) i R c , —S(O) i NR e R f , —C(═O)OR c , —OC(═O)OR c , —C(═S)OR c , —O(C═S)R c , —C(═O)NR e R f , —NR d C(═O)R c , —C(═S)NR e R f , —NR d C(═S)R c , —NR d (…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
- C07D491/107Primary
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US8980934B2 cover?
- The present teachings provide a compound represented by structural formula (I): or a pharmaceutically acceptable salt thereof. Also described are pharmaceutical compositions and methods of use thereof.
- Who is the assignee on this patent?
- Pauls Heinz W, Laufer Radoslaw, Li Sze-Wan, and 2 more
- What technology area does this patent fall under?
- Primary CPC classification C07D491/107. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Mar 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).